Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Rogler

Showing results (71-80 of 547) with videos related to

Pageof 55
Sort By:
Digestive Diseases (Basel, Switzerland)|August 23, 2016
The Search for Causative Environmental Factors in Inflammatory Bowel DiseaseGerhard Rogler, Jonas Zeitz, Luc Biedermann
Swiss Medical Weekly|March 23, 2018
New insights into the pathophysiology of inflammatory bowel disease: microbiota, epigenetics and common signalling pathwaysGerhard Rogler, Luc Biedermann, Michael Scharl
Methods in Molecular Medicine|August 2, 2007
Polymorphisms within epithelial receptors: NOD2/CARD15Julia Brenmoehl, Ernst Holler, Gerhard Rogler
Medizinische Klinik (Munich, Germany : 1983)|May 11, 2010
[Serious course of a miliary tuberculosis in a 34-year-old patient with ulcerative colitis and HIV infection under concomitant therapy with infliximab]Jonas Zeitz, Milo Huber, Gerhard Rogler
Journal of Gastrointestinal and Liver Diseases : JGLD|March 27, 2026
Endoscopic Submucosal Dissection for Colorectal Lesions in a Community-based European Hospital: Experience and Learning CurveThomas Balanis, Gerhard Rogler, Radu Tutuian
Digestive Diseases (Basel, Switzerland)|February 2, 2017
Anti-Cytokine Strategies beyond Anti-Tumour Necrosis Factor-α Therapy: Pathophysiology and Clinical ImplicationsGerhard Rogler, Luc Biedermann, Michael Scharl
Annals of the New York Academy of Sciences|August 10, 2020
Reconsidering the "protective" hypothesis of Helicobacter pylori infection in eosinophilic esophagitisMichael Doulberis, Jannis Kountouras, Gerhard Rogler
Inflammatory Intestinal Diseases|September 18, 2018
The Management of Inflammatory Bowel Disease in Elderly: Current Evidence and Future PerspectivesIan Arnott, Gerhard Rogler, Jonas Halfvarson
Swiss Medical Weekly|May 20, 2009
TNF-alpha blockers in inflammatory bowel diseases: practical consensus recommendations and a user's guideIsabelle Pache, Gerhard Rogler, Christian Felley
Clinical and Translational Gastroenterology|July 14, 2017
Fistulizing Crohn's DiseaseMichael Scharl, Gerhard Rogler, Luc Biedermann
Pageof 55

Showing results (71-80 of 547) with videos related to

Sort By:
Pageof 55
Digestive Diseases (Basel, Switzerland)|August 23, 2016
The Search for Causative Environmental Factors in Inflammatory Bowel DiseaseGerhard Rogler, Jonas Zeitz, Luc Biedermann
Swiss Medical Weekly|March 23, 2018
New insights into the pathophysiology of inflammatory bowel disease: microbiota, epigenetics and common signalling pathwaysGerhard Rogler, Luc Biedermann, Michael Scharl
Methods in Molecular Medicine|August 2, 2007
Polymorphisms within epithelial receptors: NOD2/CARD15Julia Brenmoehl, Ernst Holler, Gerhard Rogler
Medizinische Klinik (Munich, Germany : 1983)|May 11, 2010
[Serious course of a miliary tuberculosis in a 34-year-old patient with ulcerative colitis and HIV infection under concomitant therapy with infliximab]Jonas Zeitz, Milo Huber, Gerhard Rogler
Journal of Gastrointestinal and Liver Diseases : JGLD|March 27, 2026
Endoscopic Submucosal Dissection for Colorectal Lesions in a Community-based European Hospital: Experience and Learning CurveThomas Balanis, Gerhard Rogler, Radu Tutuian
Digestive Diseases (Basel, Switzerland)|February 2, 2017
Anti-Cytokine Strategies beyond Anti-Tumour Necrosis Factor-α Therapy: Pathophysiology and Clinical ImplicationsGerhard Rogler, Luc Biedermann, Michael Scharl
Annals of the New York Academy of Sciences|August 10, 2020
Reconsidering the "protective" hypothesis of Helicobacter pylori infection in eosinophilic esophagitisMichael Doulberis, Jannis Kountouras, Gerhard Rogler
Inflammatory Intestinal Diseases|September 18, 2018
The Management of Inflammatory Bowel Disease in Elderly: Current Evidence and Future PerspectivesIan Arnott, Gerhard Rogler, Jonas Halfvarson
Swiss Medical Weekly|May 20, 2009
TNF-alpha blockers in inflammatory bowel diseases: practical consensus recommendations and a user's guideIsabelle Pache, Gerhard Rogler, Christian Felley
Clinical and Translational Gastroenterology|July 14, 2017
Fistulizing Crohn's DiseaseMichael Scharl, Gerhard Rogler, Luc Biedermann
Pageof 55